ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,410
Diagnostic referrals
1,028
Outstanding pathways
306

Screening pathway

  1. Screening5,410Encounters
  2. Positive finding1,897Documented findings
  3. Referral1,028Diagnostic referrals
  4. Follow-up1,283Diagnostic visits
  5. Outcome722Resolved pathways

Stage totals use different units. Pending pathways: 306. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3232 · EXP-3232Synthetic · Site B

Full participant history through 2027-06-10, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-20
  4. · Diagnostic referral · EXP-3232-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Contact attempt · Reached
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-3232-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-02-20
  17. · Surveillance · HPV DNA · Surveillance · After treatment
  18. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3471 · Expanded synthetic participant 3471Site A — Urban Referral Hub
EXP-3472 · Expanded synthetic participant 3472Site D — Community Engagement Programme
EXP-3473 · Expanded synthetic participant 3473Site B — Peri-Urban Access Programme
EXP-3474 · Expanded synthetic participant 3474Site A — Urban Referral Hub
EXP-3475 · Expanded synthetic participant 3475Site D — Community Engagement Programme
EXP-3476 · Expanded synthetic participant 3476Site C — Rural Outreach Programme
EXP-3477 · Expanded synthetic participant 3477Site A — Urban Referral Hub
EXP-3478 · Expanded synthetic participant 3478Site A — Urban Referral Hub
EXP-3479 · Expanded synthetic participant 3479Site C — Rural Outreach Programme
EXP-3480 · Expanded synthetic participant 3480Site B — Peri-Urban Access Programme
EXP-3482 · Expanded synthetic participant 3482Site D — Community Engagement Programme
EXP-3483 · Expanded synthetic participant 3483Site E — Resource-Constrained Navigation Programme
EXP-3484 · Expanded synthetic participant 3484Site A — Urban Referral Hub
EXP-3485 · Expanded synthetic participant 3485Site B — Peri-Urban Access Programme
EXP-3486 · Expanded synthetic participant 3486Site C — Rural Outreach Programme
EXP-3487 · Expanded synthetic participant 3487Site E — Resource-Constrained Navigation Programme
EXP-3488 · Expanded synthetic participant 3488Site C — Rural Outreach Programme
EXP-3489 · Expanded synthetic participant 3489Site B — Peri-Urban Access Programme
EXP-3490 · Expanded synthetic participant 3490Site A — Urban Referral Hub
EXP-3491 · Expanded synthetic participant 3491Site E — Resource-Constrained Navigation Programme
EXP-3492 · Expanded synthetic participant 3492Site D — Community Engagement Programme
EXP-3493 · Expanded synthetic participant 3493Site C — Rural Outreach Programme
EXP-3494 · Expanded synthetic participant 3494Site D — Community Engagement Programme
EXP-3495 · Expanded synthetic participant 3495Site D — Community Engagement Programme
EXP-3496 · Expanded synthetic participant 3496Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1968
HPV DNA
2715
Cytology
727

Navigation activity

Barrier documented
930
Contact attempt
1497
Navigation intervention
417
Diagnostic booking
1298
Diagnostic visit
1283

Documented barriers

Contact difficulty
297
Transport difficulty
308
Appointment coordination
325

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.